Literature DB >> 9138836

Antimyosin antibody imaging in experimental aortic regurgitation.

P Lu1, P Zanzonico, S M Goldfine, R Hardoff, N Magid, R Gentile, E M Herrold, J S Borer.   

Abstract

BACKGROUND: Fiber dropout and myocyte necrosis precede heart failure in experimental aortic regurgitation (AR). The current study aimed to determine whether this process can be detected by noninvasive scintigraphic imaging. METHODS AND
RESULTS: 111In-labeled antimyosin antibody Fab fragment (1 to 1.5 mCi) (Myoscint) was administered to each of 34 New Zealand White rabbits: 11 early (3 to 5 weeks) after surgical AR induction; 9 late (98 to 128 weeks) after AR induction; 5 normal and 3 sham-operated age-matched with early AR; and 3 normal and 3 sham-operated age-matched with late AR. Echocardiographic fractional shortening was indistinguishable among control, early AR, and late AR groups. In vivo gamma camera imaging 24 and 48 hours after isotope administration, post-mortem heart activity determination (percentage injected dose per gram), and autoradiography were performed. At 24 and 48 hours, heart-to-lung counts-per-pixel ratios from in vivo images were greater (p < 0.05) in the late AR rabbits than in each of the three other groups. No significant differences were found when early AR and older or younger control rabbits were compared. Heart activity (percentage injected dose per gram) in late AR rabbits trended toward higher values than in age-matched control rabbits (p = 0.057), but in early AR it was indistinguishable from that in the corresponding control (p = 0.413, difference not significant). The autoradiographic endocardial/epicardial activity ratio in late AR rabbits was greater than in control and early AR rabbits (1.27 +/- 0.13 vs 1.06 +/- 0.09 and vs 1.13 +/- 0.10, respectively, p < 0.02).
CONCLUSIONS: Whereas isotope uptake in late AR rabbits differed from that in control and early AR rabbits, systolic function was indistinguishable. Thus 111In-labeled antimyosin antibody imaging may permit noninvasive detection of AR-induced myocardial damage before functional deterioration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138836     DOI: 10.1016/s1071-3581(97)90046-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  36 in total

1.  Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.

Authors:  C G Brilla; J S Janicki; K T Weber
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

2.  Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection.

Authors:  I Carrió; L Berná; M Ballester; M Estorch; D Obrador; M Cladellas; L Abadal; M Ginjaume
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

3.  High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy.

Authors:  D Obrador; M Ballester; I Carrió; L Bernà; G Pons-Lladó
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

4.  Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results.

Authors:  F Schwarz; W Flameng; J Schaper; F Langebartels; M Sesto; F Hehrlein; M Schlepper
Journal:  Am J Cardiol       Date:  1978-04       Impact factor: 2.778

5.  Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization.

Authors:  M Volpini; R Giubbini; P Gei; C Cuccia; P Franzoni; S Riva; A Terzi; M Metra; M Bestagno; O Visioli
Journal:  Am J Cardiol       Date:  1989-01-01       Impact factor: 2.778

6.  Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis.

Authors:  G W Dec; I Palacios; T Yasuda; J T Fallon; B A Khaw; H W Strauss; E Haber
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

7.  Left ventricular diastolic and systolic performance during chronic experimental aortic regurgitation.

Authors:  N M Magid; D C Wallerson; J S Borer; A Mukherjee; M S Young; R B Devereux; J N Carter
Journal:  Am J Physiol       Date:  1992-07

8.  Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments.

Authors:  B A Khaw; H K Gold; R C Leinbach; J T Fallon; W Strauss; G M Pohost; E Haber
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

9.  Heart failure due to chronic experimental aortic regurgitation.

Authors:  N M Magid; G Opio; D C Wallerson; M S Young; J S Borer
Journal:  Am J Physiol       Date:  1994-08

10.  Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue in human hearts with chronically increased volume and pressure overload.

Authors:  V Fuster; M A Danielson; R A Robb; J C Broadbent; A L Brown; L R Elveback
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

View more
  4 in total

Review 1.  Pathophysiology of valvular heart disease: implications for nuclear imaging.

Authors:  Blasé Carabello
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

3.  Guides to surgical intervention in chronic aortic regurgitation: myocytes file a claim.

Authors:  J Narula; S C Krishnan; S H Rahimtoola
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

4.  Congestive heart failure: experimental model.

Authors:  Antonio Francesco Corno; Xue Cai; Caroline B Jones; Giuseppina Mondani; Mark R Boyett; Jonathan Charles Jarvis; George Hart
Journal:  Front Pediatr       Date:  2013-10-28       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.